Lymphoid Malignancy
Showing 26 - 50 of 1,899
Chronic Lymphocytic Leukemia (CLL) Trial
Completed
- Chronic Lymphocytic Leukemia (CLL)
- (no location specified)
Apr 5, 2022
Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724
Terminated
- Non-Hodgkin's B-cell Lymphoma
- +5 more
- MT-3724 Phase 1
- MT-3724 Phase 2
-
Tucson, Arizona
- +40 more
Jul 18, 2022
Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloma Trial in Bergamo (Patient registry)
Recruiting
- Hodgkin Lymphoma
- +2 more
- Patient registry
-
Bergamo, ItalyHematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa G
Dec 22, 2021
Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)
Completed
- Lymphoma, T-Cell
- Lymphoma, Extranodal NK-T-Cell
- Alemtuzumab (Campath)
- EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Poland, Spain (Ibrutinib, OC: Ethinylestradiol (EE) 30 mcg and Levonorgestrel
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Ibrutinib
- +3 more
-
Krakow, Poland
- +3 more
Dec 3, 2019
Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)
Completed
- Lymphoma
- Leukemia
-
Darlinghurst, New South Wales, Australia
- +9 more
Mar 16, 2022
Common Variable Immunodeficiency and Related Syndromes
Recruiting
- CVID
- XLA
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
Collecting Blood and Tissue Sample Donations for Research for
Not yet recruiting
- Anal Carcinoma
- +11 more
- Biospecimen Collection
- (no location specified)
Dec 21, 2022
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Active, not recruiting
- Classical Hodgkin Lymphoma
- +12 more
-
Bedford, Bedfordshire, United Kingdom
- +8 more
Feb 22, 2022
Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)
Recruiting
- Hematopoietic Organs; Disorder
- Total lymphoid irradiation
-
Hong Kong, Hong KongHong Kong Children's Hospital
Oct 4, 2023
AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the
Active, not recruiting
- AIDS-Related Burkitt Lymphoma
- +5 more
- Prednisone
- +7 more
-
Bethesda, MarylandNCI Lymphoid Malignancies Branch
Jul 31, 2022
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
Not yet recruiting
- Acute Lymphoblastic Leukemia
- complete blood count
- (no location specified)
Feb 15, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Severe Congenital Neutropenia, GATA2 Deficiency Trial in Moscow (conditioning with TLI)
Not yet recruiting
- Severe Congenital Neutropenia
- GATA2 Deficiency
- conditioning with TLI
-
Moscow, Russian FederationHSCT department
Apr 9, 2021
Involved Nodal Irradiation vs Involved Field Irradiation After
Not yet recruiting
- Hodgkin Lymphoma
- IFRT vs NFRT
- (no location specified)
Mar 9, 2022
Optimize the Maintenance Phase of Childhood ALL
Recruiting
- Acute Lymphoblastic Leukemia
-
Trieste, ItalyIRCCS materno infantile Burlo Garofolo
Mar 31, 2023
Malignancy Trial in Shenzhen (Decitabine combined with NK cell infusion)
Recruiting
- Malignancy
- Decitabine combined with NK cell infusion
-
Shenzhen, Guangdong, ChinaShenzhen University General hospital
Nov 22, 2021
B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)
Completed
- B-cell Lymphoid Malignancies
-
Fort Myers, Florida
- +14 more
Mar 1, 2022
Cancer Survivorship in Hematologic Malignancies
Not yet recruiting
- Cancer Survivors
- questionnaire
-
Assiut, EgyptAssiut University
Mar 10, 2023
Relapsed/Refractory Multiple Myeloma Trial in United States (Belantamab mafodotin)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- Belantamab mafodotin
-
Clayton, North Carolina
- +4 more
May 16, 2023
Hematologic Malignancy Trial in Bologna
Recruiting
- Hematologic Malignancy
-
Bologna, ItalyProgramma Dipartimentale Terapie Cellulari Avanzate
Apr 17, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Non-Hodgkin
-
Copenhagen, Denmark
- +9 more
Jan 27, 2023
People Living With HIV Treated With CD19-directed CAR T Cell
Active, not recruiting
- Leukemia
- +9 more
-
Philadelphia, PennsylvaniaPennsylvania Hospital
Mar 29, 2023
Leukemia and Lymphoma in Children With Ataxia Telangiectasia
Recruiting
- Ataxia Telangiectasia
- +2 more
-
Petah Tikva, IsraelSchneider Children's Medical Center
Sep 30, 2021